SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
25 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

SRI International (SRI) is a research center that offers commercial research and development programs. The center offers research and development services for biomedical sciences and health, chemistry and materials, computing, earth and space, economic development, education and learning, energy and green tech, security and defense; and sensing and devices. Its biomedical sciences and health research services comprise addiction research, aging research, basic cancer research, behavioral health, behavioral pharmacology, bio-fuels and bio-products; bioinformatics and computational biology; biomarkers and cancer drug discovery programs.

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major

  
Source:
Document ID
GDPH43245D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
SRI International, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
SRI International, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
SRI International, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
SRI International, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
SRI International, Medical Devices Deals, 2010 to YTD 201691
SRI International, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
SRI International, Pharmaceuticals &Healthcare, Deal Details1110
  Partnerships111
    SRI Biosciences Enters into Agreement with Stanford Cancer Institute111
    SRI Biosciences Enters into Agreement with Stanford Cancer Institute121
    SRI International Enters into Contract for PREVENT Cancer Program131
    SRI International Enters into Biological Testing Facility Contract with NICHD141
    SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases151
    Lux Research Enters into Agreement with SRI International161
    Sareum And SRI International Enter Into Co-Development Agreement For Autoimmune And Inflammatory Diseases171
    Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD181
    SRI International Enters Into Collaboration With PhenoMatriX191
  Licensing Agreements201
    SRI International Enters into Licensing Agreement with Nobelpharma201
SRI International - Key Competitors211
Key Employees221
Locations And Subsidiaries232
  Head Office231
  Other Locations &Subsidiaries232
Appendix251
  Methodology251
  About GlobalData251
  Contact Us251
  Disclaimer251

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SRI-International-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13621>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/SRI-International-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-13621>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research